Nitric oxide and β₂-adrenoceptor activation attenuate pulmonary vasoconstriction during anaphylactic hypotension in anesthetized BALB/c mice

REFERENCES

• Brown AF: Anaphylactic shock: mechanisms and treatment. J Accid Emerg Med. 1995;12:89–100.
   PubMedGoogle Scholar
• Brown SG: Cardiovascular aspects of anaphylaxis: implications for treatment and diagnosis. Curr Opin Allergy Clin Immunol. 2005;5:359–364.
   PubMed Web of Science ®Google Scholar
• Sampson HA, Muñoz-Furlong A, Campbell RL, Adkinson NF Jr, Bock SA, Branum A, Brown SG, Camargo CA Jr, Cydulka R, Galli SJ, Gidudu J, Gruchalla RS, Harlor AD Jr, Hepner DL, Lewis LM, Lieberman PL, Metcalfe DD, O'Connor R, Muraro A, Rudman A, Schmitt C, Scherrer D, Simons FE, Thomas S, Wood JP, Decker WW: Second symposium on the definition and management of anaphylaxis: summary report—second. National Institute of Allergy and Infectious Disease/Food Allergy and Anaphylaxis Network symposium. Ann Emerg Med. 2006;117:391–397.
   Google Scholar
• Morel DR, Skoskiewicz M, Robinson DR, Bloch KJ, Hoaglin DC, Zapol WM: Leukotrienes, thromboxane A2, and prostaglandins during systemic anaphylaxis in sheep. Am J Physiol. 1991;261:H782–H792.
   PubMed Web of Science ®Google Scholar
• Smedegård G, Revenäs B, Lundberg C, Arfors KE: Anaphylactic shock in monkeys passively sensitized with human reaginic serum. I. Hemodynamics and cardiac performance. Acta Physiol Scand. 1981;111:239–247.
   PubMedGoogle Scholar
• Silverman HJ, Taylor WR, Smith PL, Kagey-Sobotka A, Permutt S, Lichtenstein LM, Bleecker ER: Effects of antihistamines on the cardiopulmonary changes due to canine anaphylaxis. J Appl Physiol. 1988;64:210–217.
   PubMed Web of Science ®Google Scholar
• Mink SN, Becker A, Unruh H, Kepron W: Effects of anaphylaxis mediators on partitioned pulmonary vascular resistance during ragweed shock in dogs. J Appl Physiol. 1998;84:782–790.
   PubMed Web of Science ®Google Scholar
• Halonen M, Fisher HK, Blair C, Butler C 2nd, Pinckard RN: IgE-induced respiratory and circulatory changes during systemic anaphylaxis in the rabbit. Am Rev Respir Dis. 1976;114:961–970.
   PubMed Web of Science ®Google Scholar
• Zhang W, Shibamoto T, Kuda Y, Ohmukai C, Kurata Y: Pulmonary vasoconstrictive and bronchoconstrictive responses to anaphylaxis are weakened via β2-adrenoceptor activation by endogenous epinephrine in anesthetized rats. Anesthesiology. 2011;114:614–623.
   PubMed Web of Science ®Google Scholar
• Leblais V, Delannoy E, Fresquet F, Bégueret H, Bellance N, Banquet S, Allières C, Leroux L, Desgranges C, Gadeau A, Muller B: β-adrenergic relaxation in pulmonary arteries: preservation of the endothelial nitric oxide-dependent β2 component in pulmonary hypertension. Cardiovasc Res. 2008;77: 202–210.
   PubMed Web of Science ®Google Scholar
• Pourageaud F, Leblais V, Bellance N, Marthan R, Muller B: Role of beta2-adrenoceptors (beta-AR), but not beta1-, beta3-AR and endothelial nitric oxide, in beta-AR-mediated relaxation of rat intrapulmonary artery. Naunyn Schmiedebergs Arch Pharmacol. 2005;372:14–23.
   PubMed Web of Science ®Google Scholar
• Goldie RG, Paterson JW, Lulich KM: Adrenoceptors in airway smooth muscle. Pharmacol Ther. 1990;48:295–322.
   PubMed Web of Science ®Google Scholar
• Mjörndal TO, Chesrown SE, Frey MJ, Reed BR, Lazarus SC, Gold WM: Effect of beta-adrenergic stimulation on experimental canine anaphylaxis in vivo. J Allergy Clin Immunol. 1983;71:62–70.
   PubMed Web of Science ®Google Scholar
• Silverman HJ, Taylor WR, Smith PL, Kagey-Sobotka A, Lichtenstein LM, Bleecker ER: Prevention of canine anaphylaxis with isoproterenol. Am Rev Respir Dis. 1986;134:243–247.
   PubMed Web of Science ®Google Scholar
• Amir, S., English, A.M.: An inhibitor of nitric oxide production, NG-nitro-L-arginine-methyl ester, improves survival in anaphylactic shock. Eur J Pharmacol. 1991;203:125–127.
   PubMed Web of Science ®Google Scholar
• Cauwels A, Janssen B, Buys E, Sips P, Brouckaert P: Anaphylactic shock depends on PI3K and eNOS-derived NO. J Clin Invest. 2006;116:2244–2251.
   PubMed Web of Science ®Google Scholar
• Thiemermann C: Nitric oxide and septic shock. Gen Pharmacol. 1997;29:159–166.
   PubMedGoogle Scholar
• Osada S, Ichiki H, Oku H, Ishiguro K, Kunitomo M, Semma M: Participation of nitric oxide in mouse anaphylactic hypotension. Eur J Pharmacol. 1994;252:347–350.
   PubMed Web of Science ®Google Scholar
• Kelly LJ, Undem BJ, Adams GK 3rd: Endogenous vasodilators modulate pulmonary vascular anaphylaxis. J Appl Physiol. 1994;76:916–922.
   PubMed Web of Science ®Google Scholar
• Daffonchio L, Fano M, Omini C: Rat pulmonary artery responses to some mediators of anaphylaxis: modifications by indomethacin. Pharmacol Res Commun. 1984;16:679–688.
   PubMedGoogle Scholar
• Liu W, Takano H, Shibamoto T, Cui S, Zhao ZS, Zhang W, Kurata Y: Involvement of splanchnic vascular bed in anaphylactic hypotension in anesthetized BALB/c mice. Am J Physiol Regul Integr Comp Physiol. 2007;293:R1947–R1953.
   PubMed Web of Science ®Google Scholar
• Cingolani OH, Kass DA: Pressure-volume relation analysis of mouse ventricular function. Am J Physiol Heart Circ Physiol. 2011;301:H2198–H2206.
   PubMed Web of Science ®Google Scholar
• Moore PK, Oluyomi AO, Babbedge RC, Wallace P, Hart SL: L-NG-nitro arginine methyl ester exhibits antinociceptive activity in the mouse. Br J Pharmacol. 1991;102:198–202.
   PubMed Web of Science ®Google Scholar
• Rees DD, Palmer RM, Schulz R, Hodson HF, Moncada S: Characterization of three inhibitors of endothelial nitric oxide synthase in vitro and in vivo. Br J Pharmacol. 1990;101:746–752.
   PubMed Web of Science ®Google Scholar
• Járai Z, Wagner JA, Goparaju SK, Wang L, Razdan RK, Sugiura T, Zimmer AM, Bonner TI, Zimmer A, Kunos G: Cardiovascular effects of 2-arachidonoyl glycerol in anesthetized mice. Hypertension. 2000;35:679–684.
   PubMed Web of Science ®Google Scholar
• Pumphrey RS, Roberts IS: Postmortem findings after fatal anaphylactic reactions. J Clin Pathol. 2000;53:273–276.
   PubMed Web of Science ®Google Scholar
• Brown SG, Mullins RJ, Gold MS: Anaphylaxis: diagnosis and management. Med J Aust. 2006;185:283–289.
   PubMedGoogle Scholar
• Takano H, Liu W, Zhao Z, Cui S, Zhang W, Shibamoto T: NG-nitro-L-arginine methyl ester, but not methylene blue, attenuates anaphylactic hypotension in anesthetized mice. J Pharmacol Sci. 2007;104:212–217.
   PubMed Web of Science ®Google Scholar
• Levi R, Gross SS, Lamparter B, Fasehun OA, Aisaka K, Jaffe EA, Griffith OW, Stuehr DJ: Evidence that L-arginine is the biosynthetic precursor of vascular and cardiac nitric oxide. In: Moncada S, and Higgs EA, eds. Nitric Oxide from L-Arginine: A Bioregulatory System. Amsterdam, Netherlands: Elsevier; 1990;35–45.
   Google Scholar
• Sakuma I, Gross SS, Levi R: Peptidoleukotrienes induce an endothelium-dependent relaxation of guinea pig main pulmonary artery and thoracic aorta. Prostaglandins. 1987;34:685–696.
   PubMedGoogle Scholar
• Kamata K, Mori T, Shigenobu K, Kasuya Y: Endothelium-dependent vasodilator effects of platelet activating factor on rat resistance vessels. Br J Pharmacol. 1989;98:1360–1364.
   PubMed Web of Science ®Google Scholar
• Bakhle YS, Smith TW: Tryptamine receptors in rat pulmonary artery. Br J Pharmacol. 1974;51:459–461.
   PubMed Web of Science ®Google Scholar
• Ahmed T, Marchette B, Wanner A, Yerger L: Direct and indirect effects of leukotriene D4 on the pulmonary and systemic circulations. Am Rev Respir Dis. 1985;131:554–558.
   PubMed Web of Science ®Google Scholar
• Voelkel NF, Stenmark KR, Reeves JT, Mathias MM, Murphy RC: Actions of lipoxygenase products in isolated rat lungs. J Appl Physiol. 1984;57:860–867.
   PubMed Web of Science ®Google Scholar
• Sakai A, Chang SW, Voelkel NF: Importance of vasoconstriction in lipid mediator-induced pulmonary edema. J Appl Physiol. 1989;66:2667–2674.
   PubMed Web of Science ®Google Scholar
• Russell PC, Wright CE, Barer GR, Howard P: Histamine induced pulmonary vasodilatation in the rat: site of action and changes in chronic hypoxia. Eur Respir J. 1994;7: 1138–1144.
   PubMed Web of Science ®Google Scholar
• Held HD, Martin C, Uhlig S: Characterization of airway and vascular responses in murine lungs. Br J Pharmacol. 1999;126:1191–1199.
   PubMed Web of Science ®Google Scholar
• West JB, Dollery CT, Naimark A: Distribution of blood flow in isolated lung; relation to vascular and alveolar pressures. J Appl Physiol. 1964;19:713–724.
   PubMed Web of Science ®Google Scholar
• Weissmann N, Akkayagil E, Quanz K, Schermuly RT, Ghofrani HA, Fink L, Hänze J, Rose F, Seeger W, Grimminger F: Basic features of hypoxic pulmonary vasoconstriction in mice. Respir Physiol Neurobiol. 2004;139:191–202.
   PubMed Web of Science ®Google Scholar
• Miyahara T, Shibamoto T, Wang HG, Koyama S: Role of circulating blood components and thromboxane in anaphylactic vasoconstriction in isolated canine lungs. J Appl Physiol. 1997;83:1508–1516.
   PubMed Web of Science ®Google Scholar
• Enzan K, Shouji K, Inaba H, Yoshioka N: Inhibition of pulmonary hypertensive response after antigen challenge. Shock. 1995;4:294–297.
   PubMed Web of Science ®Google Scholar